Filter
535
Filtered Results: 535
Text search:
Clinical
characterization
Featured
Recommendations
57
New Publications
88
Language
Document type
No document type
182
Guidelines
129
Studies & Reports
123
Manuals
40
Fact sheets
25
Strategic & Response Plan
24
Situation Updates
8
Training Material
3
Resource Platforms
1
Countries / Regions
Global
23
India
21
Latin America and the Carribbean
20
Africa
17
Brazil
12
Kenya
9
Nigeria
9
Western and Central Europe
9
South Africa
8
Russia
8
Colombia
7
Middle East and North Africa
7
Germany
6
West and Central Africa
6
Uganda
6
Namibia
6
Liberia
6
Sierra Leone
5
Venezuela
5
East and Southern Africa
5
Zambia
5
Western Pacific Region
4
Eastern Europe and Central Asia
4
Ghana
3
Rwanda
3
Syria
3
Zimbabwe
3
Philippines
3
Mozambique
3
USA
3
Tanzania
3
Angola
3
Tajikistan
2
Chile
2
Cameroon
2
Burkina Faso
2
Peru
2
Malawi
2
Guinea
2
Congo, Democratic Republic of
2
South–East Asia Region
2
France
2
Bolivia
2
Argentina
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Pakistan
2
Nepal
1
Ukraine
1
Lesotho
1
Turkey
1
Benin
1
Senegal
1
Afghanistan
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
Portugal
1
Southern Africa
1
Vietnam
1
Sudan
1
Ethiopia
1
South Sudan
1
Indonesia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
146
Clinical Guidelines
60
Public Health
27
Pharmacy & Technologies
20
Key Resources
11
Women & Child Health
9
Capacity Building
4
Toolboxes
COVID-19
112
Rapid Response
58
AMR
52
NTDs
38
HIV
20
TB
19
Mental Health
18
Pharmacy
18
Ebola
16
Planetary Health
15
Zika
12
NCDs
9
Cholera
6
Disability
5
Caregiver
5
Specific Hazards
4
Refugee
4
Natural Hazards
3
Conflict
3
Health Financing Toolbox
2
Polio
2
Global Health Education
2
Evaluation report
September 2014
Original Article
SAGE Open Medicine Volume 5: 1–7 © The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav httpDs:O//dIo: i1.o0r.g1/107.171/2770/52035013212171773311977 journals.sagepub.com/home/smo
China and Eurasia Forum Quarterly, Volume 6, No. 3 (2008) p. 101-128 © Central Asia-Caucasus Institute & Silk Road Studies Program
ISSN: 1653-4212
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr...
Antimicrobials are widely used in food animal production, and use is rapidly increasing.
In an era of growing demand for animal products, there is an increasing trend towards the industrial production of food animals, especially in lower- and middle-income countries (LMICs). One hallmark of this me...
Textes du Codex concernant la résistance aux antimicrobiens d’origine alimentaire
Textos del Codex sobre la resistencia a los antimicrobianos transmitida por los alimentos
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become r...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Scientific Brief 9 July 2020
Nested case-control study of health workers exposed to confirmed COVID-19 patients.
Similar objectives to the cohort study but case-control studies may be cheaper and provide robust evidence to characterize and assess the risk factors for SARS-CoV-2 infection in health workers exposed to COVID-19 p...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
